Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis

Michael P. Marciel; Vedbar S. Khadka; Youping Deng; Pascal Kilicaslan; Andrew Pham; Pietro Bertino; Katie Lee; Suzie Chen; Natalija Glibetic; FuKun W. Hoffmann; Michelle L. Matter; Peter R. Hoffmann

doi:10.18632/oncotarget.25857

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis

PDF | How to cite

Oncotarget. 2018; 9:30937-30937. https://doi.org/10.18632/oncotarget.25857

Metrics: PDF 1537 views | ?

Michael P. Marciel¹, Vedbar S. Khadka², Youping Deng², Pascal Kilicaslan³, Andrew Pham¹, Pietro Bertino¹, Katie Lee¹, Suzie Chen⁴, Natalija Glibetic⁵, FuKun W. Hoffmann¹, Michelle L. Matter⁵ and Peter R. Hoffmann¹

¹ Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, U.S.A.
² Bioinformatics Core in the Department of Complementary and Integrative Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, U.S.A.
³ Biotechnology Department, University of Applied Sciences Mannheim, Mannheim, Germany
⁴ Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, U.S.A.
⁵ The University of Hawaii Cancer Center, Honolulu, Hawaii, U.S.A.

Published: July 20, 2018

This article has been corrected: The corrected author name is given below:

Youping Deng

Original article: Oncotarget. 2018; 9:13407-13422. DOI: https://doi.org/10.18632/oncotarget.24388.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25857

Publication Alerts

Corrections:

Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis